Literature DB >> 24254308

An updated meta-analysis of transforming growth factor-β1 gene: three polymorphisms with gastric cancer.

Wei-wei Chang1, Liu Zhang, Hong Su, Ying-shui Yao.   

Abstract

To derive a more precise estimation of the relationship between TGF-β1 polymorphisms and gastric cancer (GC) risk, we conducted a meta-analysis of all available case-control studies relating the C-509 T, T869C, and G 915C polymorphisms of the TGF-β1 gene to the risk of developing GC. The effect summary odds ratio (OR) and 95% confidence intervals (CIs) were obtained. Funnel plots and Egger's test were used to estimate publication bias. Finally, 11 studies were included in the final meta-analysis. With respect to C-509 T polymorphism, it was found that significantly increased GC risk was associated with the TT genotype in the recessive genetic model in overall analysis (TT vs. CC + CT: OR = 1.23, 95% CI 1.09-1.38, P(heterogeneity) = 0.13) and in Asian population (TT vs. CC + CT: OR = 1.24, 95% CI 1.10-1.39, P(heterogeneity) = 0.18). With respect to T869C and G915C polymorphisms, no significant association with GC risk was demonstrated in overall analysis and subgroup analyses according to ethnicity for all genetic models. This meta-analysis suggested that the T allele of TGF-β1 509C/T polymorphism is probably the susceptibility factor for GC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24254308     DOI: 10.1007/s13277-013-1408-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.

Authors:  W Guo; Z Dong; Y Guo; Z Chen; Z Yang; G Kuang; B Shan
Journal:  Int J Immunogenet       Date:  2011-01-04       Impact factor: 1.466

Review 3.  Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study.

Authors:  Norihisa Saeki; Hiroe Ono; Hiromi Sakamoto; Teruhiko Yoshida
Journal:  Cancer Sci       Date:  2012-11-24       Impact factor: 6.716

4.  Comparative epidemiology of gastric cancer between Japan and China.

Authors:  Yingsong Lin; Junko Ueda; Shogo Kikuchi; Yukari Totsuka; Wen-Qiang Wei; You-Lin Qiao; Manami Inoue
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

Review 5.  Alterations in cell proliferation related gene expressions in gastric cancer.

Authors:  Kyungtae Kim; Kyung-Hee Chun; Pann-Ghill Suh; In-Hoo Kim
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

6.  [Correlation of polymorphism of Nme1-1465 T>C and TGFβ1-509 T>C with genetic susceptibility of gastric carcinoma].

Authors:  Xian-dong Lin; Chao Li; Yi Shi; Yan Chen; Li-yuan Zhang; Xiong-wei Zheng
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2010-10

7.  Prognostic significance of CD83 positive tumor-infiltrating dendritic cells and expression of TGF-beta 1 in human gastric cancer.

Authors:  Julian Ananiev; Maya Vladova Gulubova; Irena Manolova Manolova
Journal:  Hepatogastroenterology       Date:  2011 Sep-Oct

8.  Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China.

Authors:  Tao Li; Bang-Wei Cao; Yue Dai; Hong Cui; Hong-Li Yang; Chang-Qing Xu
Journal:  J Gastroenterol Hepatol       Date:  2008-03-13       Impact factor: 4.029

9.  Genetic control of the circulating concentration of transforming growth factor type beta1.

Authors:  D J Grainger; K Heathcote; M Chiano; H Snieder; P R Kemp; J C Metcalfe; N D Carter; T D Spector
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

10.  Association of transforming growth factor-beta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer.

Authors:  Pin Zhang; Jian-Zhong Di; Zhong-Zheng Zhu; Hui-Min Wu; Yu Wang; Guanshan Zhu; Qi Zheng; Lifang Hou
Journal:  Jpn J Clin Oncol       Date:  2008-10-19       Impact factor: 3.019

View more
  7 in total

1.  Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis.

Authors:  Joana Vieira de Castro; Céline S Gonçalves; Sandra Costa; Paulo Linhares; Rui Vaz; Ricardo Nabiço; Júlia Amorim; Marta Viana-Pereira; Rui M Reis; Bruno M Costa
Journal:  Tumour Biol       Date:  2015-03-27

2.  Effect of interleukin-1β and tumor necrosis factor α gene silencing on mouse gastric cancer cell proliferation and migration.

Authors:  Zhongwei Sun; Yan Meng; Guoqin Liu; Yongsheng Jiang; Qinghua Meng; Sanyuan Hu
Journal:  Oncol Lett       Date:  2016-02-19       Impact factor: 2.967

3.  Polymorphisms of TGFBR1, TLR4 are associated with prognosis of gastric cancer in a Chinese population.

Authors:  Bangshun He; Tao Xu; Bei Pan; Yuqin Pan; Xuhong Wang; Jingwu Dong; Huiling Sun; Xueni Xu; Xiangxiang Liu; Shukui Wang
Journal:  Cancer Cell Int       Date:  2018-11-20       Impact factor: 5.722

4.  Non-random distribution of gastric cancer susceptible loci on human chromosomes.

Authors:  Ghazale Mahjoub; Mostafa Saadat
Journal:  EXCLI J       Date:  2018-08-17       Impact factor: 4.068

5.  Association between TGF-β1 Polymorphisms and Head and Neck Cancer Risk: A Meta-Analysis.

Authors:  Quan Shi; Xing Wang; Chuan Cai; Shuo Yang; Na Huo; Hongchen Liu
Journal:  Front Genet       Date:  2017-11-03       Impact factor: 4.599

6.  The Influence of Family History on Stage and Survival of Gastric Cancer According to the <i>TGFB1</i> C-509T Polymorphism in Korea.

Authors:  Hee Jin Kim; Mingu Kwon; Nayoung Kim; Jae Bong Lee; Sungho Won
Journal:  Gut Liver       Date:  2020-01-15       Impact factor: 4.519

7.  Cytokine TGF-β1, TNF-α, IFN-γ and IL-6 Gene Polymorphisms and Localization of Premalignant Gastric Lesions in Immunohistochemically H. pylori-negative Patients.

Authors:  Anca Negovan; Mihaela Iancu; Florin Tripon; Andrei Crauciuc; Simona Mocan; Claudia Bănescu
Journal:  Int J Med Sci       Date:  2021-05-21       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.